Interpace Biosciences, Inc.
IDXG· OTC
IDXGInterpace Biosciences, Inc.
Filed Mar 15, 2013 · 10-K · 74 days after period end · 0001054102-13-000005
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $35.63M | $38.28M | — |
| Net Income | -$23.80M | -$10.27M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Interpace Biosciences, Inc. · CIK 1054102 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 15, 2013 · 74 d after period end
